TY  - JOUR

T1  - Risk-adjusted prognostic models for Hodgkin's disease (HD) and grade II non-Hodgkin's lymphoma (NHL II): validation on 6728 British National Lymphoma Investigation patients.

JO  - Br J Haematol

PY  - 2003/01/01

AU  - Low SE

AU  - Horsman JM

AU  - Walters SJ

AU  - Hancock H

AU  - Smith P

AU  - Linch D

AU  - Hancock BW

ED  - 

DO  - DOI: 10.1046/j.1365-2141.2003.04061.x

VL  - 120

IS  - 2

SP  - 277

EP  - 280

Y2  - 2024/12/22

ER  -